Treace Medical Concepts Income Statement (2020-2026) | TMCI

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter)
20.65M21.62M33.44M29.05M29.97M33.05M49.77M42.20M41.95M40.76M62.21M51.11M44.45M45.09M68.71M52.57M47.39M50.21M62.52M47.20M
Cost of Revenue (Quarter)
3.94M4.25M5.37M5.13M5.29M6.09M9.02M8.04M7.67M8.00M11.47M10.13M8.78M8.95M13.23M10.68M9.63M10.51M12.12M9.79M
Gross Profit (Quarter)
16.71M17.37M28.07M23.92M24.68M26.96M40.75M34.16M34.28M32.76M50.74M40.98M35.67M36.13M55.48M41.89M37.75M39.71M50.40M37.41M
Operating items
Research & Development (Quarter)
2.42M2.54M3.38M3.05M2.98M3.80M-60.89M3.41M3.53M33.54M39.92M40.33M37.68M32.77M5.21M5.56M33.08M4.68M37.25M4.62M
Selling, General & Administrative (Quarter)
4.33M4.31M7.03M6.66M7.01M8.92M10.41M10.87M10.03M12.69M13.45M14.36M14.22M13.53M13.61M15.79M16.14M16.28M14.53M16.18M
Other Operating Expenses (Quarter)
14.01M15.98M23.26M0.00M-0.00M-0.04M-0.36M0.13M0.10M0.02M0.10M0.07M0.11M0.02M0.12M0.13M0.12M0.09M0.09M0.28M
Operating Expenses (Quarter)
20.76M22.83M33.67M32.01M36.61M38.28M44.24M47.93M47.33M50.58M57.52M59.95M57.06M51.27M55.68M57.48M54.73M55.38M56.32M54.57M
Operating Income (Quarter)
-4.05M-5.46M-5.60M-8.10M-11.93M-11.32M-3.50M-13.78M-13.05M-17.82M-6.78M-18.97M-21.38M-15.13M-0.20M-15.58M-16.97M-15.68M-5.92M-17.17M
EBIT (Quarter)
-4.05M-5.46M-5.60M-8.10M-11.93M-11.32M-3.50M-13.78M-13.05M-17.82M-6.78M-18.97M-21.38M-15.13M-0.20M-15.58M-16.97M-15.68M-5.92M-17.17M
Non-operating items
Non Operating Investment Income (Quarter)
-0.03M-0.03M-0.16M0.07M0.31M-0.09M-0.10M0.22M-0.09M-0.04M-0.01M0.03M-0.01M-0.10M
Interest & Investment Income (Quarter)
0.01M0.01M0.01M0.01M0.13M0.42M0.75M1.48M1.97M1.57M1.71M1.53M1.38M1.07M0.90M0.84M0.78M0.63M0.53M0.50M
Other Non Operating Income (Quarter)
-1.03M-0.96M3.02M-0.94M4.48M-0.81M0.32M0.78M0.30M0.50M0.29M0.18M-0.23M-0.24M-0.34M-0.42M-0.61M2.70M-0.79M
Net income details
EBT (Quarter)
-236.75M-199.46M-6.58M-34.89M-15.23M-12.09M-4.05M-13.58M-12.37M-17.54M-6.38M-18.75M-21.32M-15.38M-0.87M-16.05M-17.52M-16.38M-6.96M-20.85M
Profit After Tax (Quarter)
-5.08M-6.42M-6.62M-9.04M-17.23M-12.13M-4.41M-13.45M-12.27M-17.52M-5.97M-18.68M-21.21M-15.14M-0.57M-15.92M-17.40M-16.29M-9.39M-18.06M
Income from Continuing Operations (Quarter)
-236.75M-199.46M-6.58M-34.89M-15.23M-12.09M-4.05M-13.58M-12.37M-17.54M-6.38M-18.75M-21.32M-15.38M-0.87M-16.05M-17.52M-16.38M-6.96M-20.85M
Consolidated Net Income (Quarter)
-236.75M-199.46M-6.58M-34.89M-15.23M-12.09M-4.05M-13.58M-12.37M-17.54M-6.38M-18.75M-21.32M-15.38M-0.87M-16.05M-17.52M-16.38M-6.96M-20.85M
Income towards Parent Company (Quarter)
-236.75M-199.46M-6.58M-34.89M-15.23M-12.09M-4.05M-13.58M-12.37M-17.54M-6.38M-18.75M-21.32M-15.38M-0.87M-16.05M-17.52M-16.38M-6.96M-20.85M
Preferred Dividend Payments (Quarter)
0.04M
Net Income towards Common Stockholders (Quarter)
-5.12M-6.42M-6.62M-9.04M-17.23M-12.13M-4.41M-13.58M-12.37M-17.54M-6.38M-18.75M-21.32M-15.38M-0.87M-16.05M-17.52M-16.38M-6.96M-20.85M
Additional items
EPS (Basic) (Quarter)
-0.10-0.12-0.14-0.16-0.31-0.22-0.08-0.23-0.20-0.28-0.10-0.30-0.34-0.25-0.01-0.26-0.28-0.26-0.11-0.32
EPS (Diluted) (Quarter)
-0.10-0.12-0.14-0.16-0.31-0.22-0.08-0.23-0.20-0.28-0.10-0.30-0.34-0.25-0.01-0.26-0.28-0.26-0.11-0.32
Shares Outstanding (Quarter)
49.19M52.77M48.42M54.83M55.31M55.43M55.28M58.72M61.38M61.56M60.85M61.79M62.08M62.23M62.11M62.66M63.01M63.52M63.27M64.59M
Shares Outstanding (Diluted) (Quarter)
49.19M52.77M48.42M54.83M55.31M55.43M55.28M58.72M61.38M61.56M60.85M61.79M62.08M62.23M62.11M62.66M63.01M63.52M63.27M64.59M
EBITDA (Quarter)
-4.05M-5.46M-5.60M-8.10M-11.93M-11.32M-3.50M-13.78M-13.05M-17.82M-6.78M-18.97M-21.38M-15.13M-0.20M-15.58M-16.97M-15.68M-5.92M-17.17M
Interest Expenses (Quarter)
232.70M194.00M0.98M26.80M3.43M1.19M1.31M1.28M1.28M1.30M1.30M1.32M1.31M1.31M1.57M1.31M1.32M1.34M1.57M4.18M